CS203054B2 - Method of preparing imidazolyl compounds - Google Patents
Method of preparing imidazolyl compounds Download PDFInfo
- Publication number
- CS203054B2 CS203054B2 CS764839A CS483976A CS203054B2 CS 203054 B2 CS203054 B2 CS 203054B2 CS 764839 A CS764839 A CS 764839A CS 483976 A CS483976 A CS 483976A CS 203054 B2 CS203054 B2 CS 203054B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- methyl
- formula
- compounds
- solution
- reacted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB31968/75A GB1565647A (en) | 1975-07-31 | 1975-07-31 | Pharmacologically active compounds 4-substituted-imidazole-5-methanols |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS203054B2 true CS203054B2 (en) | 1981-02-27 |
Family
ID=10331071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS764839A CS203054B2 (en) | 1975-07-31 | 1976-07-21 | Method of preparing imidazolyl compounds |
Country Status (28)
| Country | Link |
|---|---|
| JP (1) | JPS5219663A (ro) |
| AR (1) | AR213100A1 (ro) |
| AT (1) | AT356668B (ro) |
| AU (1) | AU508262B2 (ro) |
| BE (1) | BE843840A (ro) |
| CA (1) | CA1075702A (ro) |
| CS (1) | CS203054B2 (ro) |
| DD (1) | DD125205A5 (ro) |
| DE (1) | DE2634430A1 (ro) |
| DK (1) | DK316376A (ro) |
| ES (1) | ES450309A1 (ro) |
| FI (1) | FI762191A (ro) |
| FR (1) | FR2319341A1 (ro) |
| GB (1) | GB1565647A (ro) |
| GR (1) | GR61114B (ro) |
| HU (1) | HU174068B (ro) |
| IL (1) | IL50006A0 (ro) |
| LU (1) | LU75495A1 (ro) |
| NL (1) | NL7608505A (ro) |
| NO (1) | NO762659L (ro) |
| OA (1) | OA05405A (ro) |
| PH (1) | PH13417A (ro) |
| PT (1) | PT65377B (ro) |
| RO (1) | RO72312B (ro) |
| SE (1) | SE7608478L (ro) |
| SU (1) | SU655310A3 (ro) |
| ZA (1) | ZA763686B (ro) |
| ZM (1) | ZM9676A1 (ro) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ186965A (en) | 1977-04-20 | 1980-02-21 | Ici Ltd | Guanidino derivatives and pharmaceutical compositions |
| US4165378A (en) | 1977-04-20 | 1979-08-21 | Ici Americas Inc. | Guanidine derivatives of imidazoles and thiazoles |
| USRE31588E (en) * | 1977-06-03 | 1984-05-22 | Bristol-Myers Company | Imidazolylmethylthioethyl alkynyl guanidines |
| US4112234A (en) | 1977-08-22 | 1978-09-05 | Bristol-Myers Company | Imidazolylmethylthioethyl alkynyl guanidines |
| US4233302A (en) | 1977-12-23 | 1980-11-11 | Glaxo Group Limited | Amine derivatives and pharmaceutical compositions containing them |
| EP0008596A1 (fr) * | 1978-09-04 | 1980-03-19 | DEVINTER Europe S.A. Société anonyme dite: | Procédé de préparation de dérivés du type 4-hydroxyméthyl imidazole à partir d'esters d'acides 4-imidazole carboxyliques correspondants |
| US4200760A (en) * | 1978-09-26 | 1980-04-29 | Bristol-Myers Company | Imidazolylalkylthioalkylamino-ethylene derivatives |
| JPS5914460B2 (ja) * | 1978-12-27 | 1984-04-04 | 相互薬工株式会社 | Ｈ↓２受容体「きつ」抗剤シメチジンの製造法 |
| CN103288742A (zh) * | 2013-06-04 | 2013-09-11 | 四川百利药业有限责任公司 | 一种高纯度英加韦林原料的制备方法 |
| US20230349922A1 (en) | 2020-08-11 | 2023-11-02 | Université De Strasbourg | H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA938556A (en) * | 1970-06-25 | 1973-12-18 | Smith Kline And French Laboratories Limited | Pharmaceutical compositions containing thiourea derivatives |
-
1975
- 1975-07-31 GB GB31968/75A patent/GB1565647A/en not_active Expired
-
1976
- 1976-06-21 ZA ZA763686A patent/ZA763686B/xx unknown
- 1976-07-06 BE BE168682A patent/BE843840A/xx not_active IP Right Cessation
- 1976-07-09 PH PH18667A patent/PH13417A/en unknown
- 1976-07-09 IL IL50006A patent/IL50006A0/xx unknown
- 1976-07-13 DK DK316376A patent/DK316376A/da unknown
- 1976-07-16 PT PT65377A patent/PT65377B/pt unknown
- 1976-07-20 FR FR7622069A patent/FR2319341A1/fr active Granted
- 1976-07-21 CS CS764839A patent/CS203054B2/cs unknown
- 1976-07-22 CA CA257,589A patent/CA1075702A/en not_active Expired
- 1976-07-23 ZM ZM96/76A patent/ZM9676A1/xx unknown
- 1976-07-27 SE SE7608478A patent/SE7608478L/xx unknown
- 1976-07-27 GR GR51356A patent/GR61114B/el unknown
- 1976-07-27 AT AT552376A patent/AT356668B/de not_active IP Right Cessation
- 1976-07-29 LU LU75495A patent/LU75495A1/xx unknown
- 1976-07-30 NL NL7608505A patent/NL7608505A/xx not_active Application Discontinuation
- 1976-07-30 DE DE19762634430 patent/DE2634430A1/de not_active Withdrawn
- 1976-07-30 NO NO762659A patent/NO762659L/no unknown
- 1976-07-30 JP JP51092242A patent/JPS5219663A/ja active Pending
- 1976-07-30 SU SU762386215A patent/SU655310A3/ru active
- 1976-07-30 AR AR264157A patent/AR213100A1/es active
- 1976-07-30 DD DD194154A patent/DD125205A5/xx unknown
- 1976-07-30 FI FI762191A patent/FI762191A/fi not_active Application Discontinuation
- 1976-07-30 HU HU76SI1532A patent/HU174068B/hu unknown
- 1976-07-30 ES ES450309A patent/ES450309A1/es not_active Expired
- 1976-07-30 AU AU16447/76A patent/AU508262B2/en not_active Expired
- 1976-07-31 RO RO87167A patent/RO72312B/ro unknown
- 1976-07-31 OA OA55903A patent/OA05405A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR61114B (en) | 1978-09-13 |
| ATA552376A (de) | 1979-10-15 |
| AU1644776A (en) | 1978-02-02 |
| CA1075702A (en) | 1980-04-15 |
| RO72312A (ro) | 1984-03-15 |
| FR2319341B1 (ro) | 1979-01-12 |
| FR2319341A1 (fr) | 1977-02-25 |
| SU655310A3 (ru) | 1979-03-30 |
| PT65377A (en) | 1976-08-01 |
| JPS5219663A (en) | 1977-02-15 |
| PH13417A (en) | 1980-03-30 |
| AT356668B (de) | 1980-05-12 |
| ZA763686B (en) | 1977-05-25 |
| BE843840A (fr) | 1977-01-06 |
| NO762659L (ro) | 1977-02-01 |
| SE7608478L (sv) | 1977-02-01 |
| AR213100A1 (es) | 1978-12-15 |
| IL50006A0 (en) | 1976-09-30 |
| NL7608505A (nl) | 1977-02-02 |
| DK316376A (da) | 1977-02-01 |
| GB1565647A (en) | 1980-04-23 |
| LU75495A1 (ro) | 1977-03-03 |
| FI762191A (ro) | 1977-02-01 |
| OA05405A (fr) | 1981-02-28 |
| HU174068B (hu) | 1979-10-28 |
| DD125205A5 (ro) | 1977-04-06 |
| AU508262B2 (en) | 1980-03-13 |
| ES450309A1 (es) | 1977-12-01 |
| RO72312B (ro) | 1984-03-31 |
| PT65377B (en) | 1978-01-19 |
| DE2634430A1 (de) | 1977-02-10 |
| ZM9676A1 (en) | 1977-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Van der Goot et al. | Isothiourea analogues of histamine as potent agonists or antagonists of the histamine H3-receptor | |
| Durant et al. | The histamine h2-receptor agonist impromidine: Synthesis and structure activity considerations | |
| SU843746A3 (ru) | Способ получени аминотиазоловили иХ КиСлОТНО-АддиТиВНыХ СОлЕй | |
| EP0049618B1 (en) | Improvements in or relating to 2,4-disubstituted thiazole derivatives | |
| SE416049B (sv) | Forfarande for framstellning av 1,1-diaminoctylenderivat, som kan anvendas for hemning av vissa histaminverkningar | |
| IE41856B1 (en) | Process for the preparation of heterocyclic substituted thioureas and n-cyanoguanidines | |
| DK145541B (da) | Analogifremgangsmaade til fremstilling af urinstofderivater indeholdende en imidazolylgruppe | |
| CS203054B2 (en) | Method of preparing imidazolyl compounds | |
| HU207945B (en) | Process for producing neuropeptide-y-antagonisticpharmaceutical compositions containing imidazolyl-alkyl-guanidine derivative | |
| US4301165A (en) | Pharmacologically active compounds | |
| NO762661L (ro) | ||
| FI62530B (fi) | Foerfarande foer framstaellning av n-(2-(imidazolyl- eller pyridyl-metyltio)-etyl)-amidinosulfonsyraderivat vilka aer aktiva som histamin-h2-receptor-antagonister | |
| US4013659A (en) | Certain n,n'-disubstituted guanidine compounds and their use | |
| HU182461B (en) | Process for producing new h-2 down-receptore antagonistic thiazole derivatives | |
| JPS6343391B2 (ro) | ||
| FI79301B (fi) | Foerfarande foer framstaellning av 4-metyl-5- alkyltiometylimidazoler. | |
| CS207750B2 (en) | Method of making the n'-cyano-n'-alcyl-n-2-/5-methyl-1h-imidazol-4-yl/methyl thicethyl guanidines | |
| US2748122A (en) | 2-anilino-4, 6-dimethylpyrimidines | |
| CA1118445A (en) | N,n'-[bis(n-cyanoguanyl)] crystamine derivatives | |
| AU2010305397B2 (en) | Method for the synthesis of 2-thiohistidine and the like | |
| NO781572L (no) | Fremgangsmaate for fremstilling av bisamidiner | |
| FI63753C (fi) | Foerfarande foer framstaellning av kristallint simetidin. | |
| EP0173377A2 (en) | Pyrimidone compounds, their preparation and pharmaceutical compositions containing them | |
| NO772669L (no) | Fremgangsm}te for fremstilling av farmakologisk aktive forbindelser | |
| JPS6030310B2 (ja) | イミダゾールの製法 |